Pazopanib in Treating Patients With Recurrent or Metastatic Breast Cancer

NCT00509587 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

NIH

Sponsor class

Conditions

Breast Cancer
Recurrent Breast Cancer
Stage IV Breast Cancer

Interventions

DRUG: pazopanib hydrochloride
PROCEDURE: pharmacological study
PROCEDURE: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)